We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

23 Mar 2018 15:25

RNS Number : 8159I
Surgical Innovations Group PLC
23 March 2018
 

 

Surgical Innovations Group plc 

("SI Group" or "the Company")

 

Director/PDMR Shareholding

 

 

The Company was notified on 23 March 2018 that on 22 March 2018 Melanie Ross, Chief Operating Officer, purchased 483,998 ordinary shares of 1 penny each in the Company ("Shares") for her ISA and her husband, Lee Ross purchased 483,998  Shares for his ISA, both at a price of 3.753p per share. To facilitate these purchases, also on 22 March 2018, Melanie Ross sold 967,996 Shares at a price of 3.75p each.

 

In addition, on 23 March 2018 Melanie Ross purchased 504,644 Shares at a price of 3.57p per share in an off-market transaction from Hardy Transaction Management Limited, which is wholly owned by Paul Hardy, a Non-Executive Director of the Company.

 

Following the transactions, the combined beneficial holding of Melanie Ross and her husband in the Company is 2,078,354 Shares, representing approximately 0.27% of the issued share capital and the beneficial holding of Paul Hardy is 6,225,541 Shares, representing 0.80% of the issued share capital.

 

 

 

For further information please contact:

 

Surgical Innovations Group Plc

www.sigroupplc.com

Nigel Rogers, Executive Chairman

Tel: 0113 230 7597

Melanie Ross, COO & Finance Director

WH Ireland Limited (NOMAD & Broker)

Tim Feather / Alex Bond

 

Tel: 0113 394 6600

 

Walbrook PR (Financial PR & Investor Relations)

Tel: 020 7933 8780 or si@walbrookpr.com

Paul McManus

Mob: 07980 541 893

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Melanie Ross

2

Reason for the notification

a)

Position/status

Chief Operating Officer, Surgical Innovations Group plc

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Surgical Innovations Group plc

b)

LEI

2138004GHGUH3HUZE156

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1p

 

 

 

GB0004016704

b)

Nature of the transactions

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

3.75p

967,996

d)

Aggregated information

- Aggregated volume

- Price

 

 

967,996

£36,300

e)

Date of the transaction

22 March 2018

 

f)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Melanie Ross

2

Reason for the notification

a)

Position/status

Chief Operating Officer, Surgical Innovations Group plc

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Surgical Innovations Group plc

b)

LEI

2138004GHGUH3HUZE156

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1p

 

 

 

GB0004016704

b)

Nature of the transactions

1. Purchase of shares in ISA

2. Purchase of shares by husband

3. Purchase of shares

5.

Price(s) and volume(s)

Price(s)

Volume(s)

3.75p

483,998

3.75p

483,998

3.57p

504,644

d)

Aggregated information

- Aggregated volume

- Price

 

1,472,640

£54,316

e)

Date of the transaction

1. & 2. - 22 March 2018

3.- 23 March 2018

f)

Place of the transaction

1. & 2. - London Stock Exchange, AIM

3. - Off market

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Paul Hardy

2

Reason for the notification

a)

Position/status

Non-Executive Director, Surgical Innovations Group plc

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Surgical Innovations Group plc

b)

LEI

2138004GHGUH3HUZE156

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1p

 

 

 

GB0004016704

b)

Nature of the transactions

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

3.57p

504,644

d)

Aggregated information

- Aggregated volume

- Price

 

504,644

£18,016

e)

Date of the transaction

23 March 2018

f)

Place of the transaction

Off market

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBUGDXXDDBGIX
Date   Source Headline
18th Apr 20247:01 amRNSFinal Results
18th Apr 20247:00 amRNSNew exclusive UK distribution agreements secured
9th Apr 20247:00 amRNSDirectorate Change & Notice of Results
29th Jan 20247:00 amRNSYear-end 2023 Trading Update
19th Dec 20237:00 amRNSDirectorate Change
5th Dec 20237:00 amRNSDirectorate Change
19th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSTrading Update and Notice of Results
27th Jun 202312:12 pmRNSResult of AGM
27th Jun 20237:00 amRNSAGM Statement
26th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
25th May 202311:11 amRNSDirector/PDMR Shareholding - Replacement
25th May 20237:00 amRNSDirector/PDMR Shareholding
22nd May 20237:00 amRNSDirectorate changes and board succession planning
29th Mar 20237:00 amRNSFinal Results
3rd Mar 20237:00 amRNSNotice of Results and Investor Presentation
23rd Jan 20237:00 amRNSYear-end Trading Update
21st Sep 20227:00 amRNSHalf-year Report
2nd Sep 20227:00 amRNSNotice of Interim Results
27th Jun 20223:15 pmRNSResult of AGM
27th Jun 20227:00 amRNSAGM Trading Statement
25th May 20227:00 amRNSPosting of 2021 Annual Report & Accounts
9th May 202212:41 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSFinal Results
21st Mar 20227:00 amRNSProduct launch in partnership with CMR Surgical
10th Mar 20227:00 amRNSNotice of Annual Results
17th Jan 20227:00 amRNSYear-end Trading Update
15th Nov 20217:00 amRNSChanges to Board Structure & CFO Appointment
10th Nov 20215:43 pmRNSGrant of Options
15th Sep 20217:00 amRNSHalf-year Report
27th Aug 20217:00 amRNSNotice of Interim Results
9th Jul 20212:29 pmRNSDirector/PDMR Shareholding
22nd Jun 20215:26 pmRNSResult of AGM
22nd Jun 20217:00 amRNSAGM Trading Statement
21st Jun 20217:00 amRNSWithdrawal of AGM Resolution
21st May 20217:00 amRNSPosting of Annual Report& Accounts & Notice of AGM
25th Mar 20217:00 amRNSFinal Results
22nd Mar 20217:00 amRNS3-year Exclusive UK distribution agreement
8th Mar 20217:00 amRNSNotice of annual results
15th Feb 20217:00 amRNS5-year USA distribution agreement
9th Feb 20217:00 amRNSLaunch of the Green Surgery Challenge
8th Jan 20217:00 amRNSDistalmotion’s Dexter Robot receives CE Mark
7th Jan 20217:00 amRNSFuture board change
21st Dec 20207:00 amRNSTrading update
17th Dec 20207:00 amRNSUS distribution agreement signed with Adler
7th Dec 20203:00 pmRNSReplacement of Auditor
2nd Dec 20207:00 amRNSProduct launch for Cellis Breast
25th Nov 20207:00 amRNSCentre for Sustainable Healthcare collaboration
25th Sep 202011:50 amRNSHolding(s) in Company
23rd Sep 20205:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.